HTA55 USA Vs. Global Pharmaceutical Launches: What Are the Potential Reasons That Can Result in a Pharmaceutical Not Being Commercialized Outside the USA?
| Autor: | Taxak HSNT, Nikhil, Ismailoglu, I, Hunt, M |
|---|---|
| Zdroj: | In Value in Health June 2024 27(6) Supplement:S254-S254 |
| Databáze: | ScienceDirect |
| Externí odkaz: |
|
Full Text from ScienceDirect